Malabsorption syndrome is a disorder that occurs when a person is incapable to absorb certain nutrients such as proteins, carbohydrates, fats, vitamins, and minerals from the diet.
Malabsorption Syndrome Treatment Market: Introduction
- Malabsorption syndrome is a disorder that occurs when a person is incapable to absorb certain nutrients such as proteins, carbohydrates, fats, vitamins, and minerals from the diet. A few common disorders associated with malabsorption syndrome are celiac disease and lactose intolerance. Patients with the history of stomach and bowel surgery can also suffer from malabsorption syndrome.
Read Report Overview - https://www.transparencymarketresearch.com/malabsorption-syndrome-treatment-market.html
- Malabsorption syndrome can occur if an individual does not have enough amount of enzymes in the body; foreign invaders or bacteria are present in the body; or movement in the large or small intestine is more rapid than usual
- Depending on severity of the condition, cause, and how long the patient has had the disorder, symptoms of malabsorption syndrome may vary
- The most common symptoms of malabsorption syndrome are stomach cramping, diarrhea, gas, fatigue, bloating and stomach distention, stools that appear ‘greasy’ in texture, steatorrhea or stool that is pale white to white in color, and weakness
- For confirmation of the diagnosis of malabsorption syndrome, healthcare professionals recommend the stool test, blood test, breathe test, or imaging test to the patient
- Treatment of malabsorption syndrome depends on type or cause of the disease. Some of the treatment options for malabsorption syndrome are antidiarrheal agents, diet changes, antibiotics, various vitamins, intestinal hormones, medium-chain triglycerides, minerals, anti-inflammatory medications or steroids, and acid-reducing drugs.
Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=76329
Key Drivers of Global Malabsorption Syndrome Treatment Market
- Increase in the number of people with diseases such as celiac disease, short bowel syndrome, and other intestinal disorders is expected to drive the global malabsorption syndrome treatment market during the forecast period
- According to a study published by Celiac Disease Foundation, currently, the rate of global prevalence of malabsorption syndrome is estimated to be 1.4%, based on the blood test, and 0.7%, based on biopsy. The rate of prevalence of celiac disease was 08% in Europe and Oceania; 0.6% in Asia; 0.5% in Africa and North America; and 0.4% in South America.
Crohn’s Disease Segment to Expand at a Rapid Rate
- In terms of disease condition, the global malabsorption syndrome treatment market can be divided into celiac disease, Crohn’s disease, Whipple’s disease, short bowel syndrome, intestinal disorders, and others
- The Crohn’s disease segment is anticipated to expand at a rapid rate during the forecast period, due to increase in the number of patients with Crohn’s disease
- According to a study published in the Journal of Gastroenterology & Hepatology 2019, inflammatory bowel diseases including Crohn’s disease and ulcerative colitis are relapsing and chronic disorders of the gastrointestinal tract. Currently, over 1.5 million people in North America and 2 million people in Europe have inflammatory bowel disease.
Request for TOC @ https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=76329
Retail Pharmacies Segment to Witness Attractive Opportunities
- Based on distribution channel, the global malabsorption syndrome treatment market can be classified into hospital pharmacies, retail pharmacies, and others
- The retail pharmacies segment is expected to account for a major share of the global malabsorption syndrome treatment market by 2027, due to purchase of specialty drugs through retail pharmacies
North America to Dominate Global Malabsorption Syndrome Treatment Market
- In terms of region, the global malabsorption syndrome treatment market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is projected to dominate the global market during the forecast period.
- Significant economic growth, increased investments, and risen prevalence of causative diseases, such as diarrhea, lactose intolerance, and cystic fibrosis, in the region are factors expected to drive the malabsorption syndrome treatment market in North America during the forecast period.
Pre Book Malabsorption Syndrome Treatment Market Report at https://www.transparencymarketresearch.com/checkout.php?rep_id=76329<ype=S
Key Players Operating in Global Market
Key players operating in the global malabsorption syndrome treatment market are:
- GlaxoSmithKline plc
- Glenmark Pharmaceuticals
- Abbvie, Inc.
- Actelion Pharmaceuticals
- AstraZeneca plc
- Bayer AG
- Eli Lily and Company
- Lupin Pharmaceuticals, Inc.
- Sanofi
- Pfizer Inc.
- Hoffmann-La Roche Ltd
- Gilead Sciences, Inc.
- Mallinckrodt Pharmaceuticals
- DSM
Browse more Reports by Transparency Market Research:
Diabetes Devices Market: Rise in prevalence of diabetes across the U.S. and Asia is anticipated to boost the growth of the diabetes management market due to a relative increase in demand for insulin delivery devices.
Genome Engineering Market: Pharmaceutical firms have realized the new trends of treating genetic diseases by gene editing technologies. They are collaborating with gene editing companies to develop treatment option.
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
Contact
Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com/